• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN VISTEC; GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN VISTEC; GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE Back to Search Results
Model Number 7462
Device Problem Material Separation (1562)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/24/2018
Event Type  malfunction  
Manufacturer Narrative
Submit date: 6-14-2018.The complainant indicated that the device will not be returned for evaluation; therefore, a failure analysis is not available, and we are not able to determine the relationship between this device and the cause for this event.As part of our manufacturing process, all device history records are reviewed and approved by quality, prior to release of product.If additional information or the sample is received, the investigation will be reopened and responded to accordingly.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The customer reported x-ray gauze shredded and causing lint concerns.
 
Manufacturer Narrative
Submission date: (b)(6) 2018.An investigation was performed for the reported customer complaint: ¿the customer reported x-ray gauze shredded and causing lint concerns.¿ a review of the device history record (dhr) for lot no.17k182062 indicated the product was released meeting all quality standards.All dhrs are reviewed for accuracy prior to product release.In-process procedures are also in place to prevent nonconforming product in the manufacturing process.This ensures components and finished products meet all quality inspection standards.These controls include, but are not limited to: material verification/certification processes, dimensional specifications, statistical samplings, periodic audits, process inspections, machine maintenance/operation and personnel training and certification.There was one (1) sponge returned for evaluation.The product was opened and examined for fraying.During visual examination and cross examination of the sponge, fraying was observed.The reason for fraying in the product is due to the tinsel strength of the woven material becoming weak.This can occur during production when the material is pulled during the cutting process.The material can break.The location of the tear would not easily be observed during a visual inspection in production.Inspectors routinely examine a statistical sample both physically and visually.If the material did a complete tear out, then the roll would be evaluated.The lots must be deemed acceptable by passing inspections that are based on a valid sampling plan.The reported customer complaint is confirmed.The root cause was determined to be material weakened during production process.This complaint will be utilized for tracking and trending purposes.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISTEC
Type of Device
GAUZE/SPONGE, INTERNAL, X-RAY DETECTABLE
Manufacturer (Section D)
COVIDIEN
1647 perkins rd
augusta GA 30913
MDR Report Key7602530
MDR Text Key111148444
Report Number1018120-2018-00085
Device Sequence Number1
Product Code GDY
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 08/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number7462
Device Catalogue Number7462
Device Lot Number17K182062
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/06/2018
Initial Date FDA Received06/14/2018
Supplement Dates Manufacturer Received06/25/2018
Supplement Dates FDA Received08/24/2018
Patient Sequence Number1
-
-